EN
HI
Summary
As of 20 Sep, 2026, Akums Drugs & Pharmaceuticals stock price is ₹783.7. During the trading session, the stock has moved between an intraday low of ₹767.10 and an intraday high of ₹790.00. Over the last 52 weeks, Akums Drugs & Pharmaceuticals has traded between ₹409.30 and ₹796.55.
The stock has recorded a trading volume of 3,30,477 shares,. Its Average Traded Price (ATP) is ₹778.82, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹783.70.
Akums Drugs & Pharmaceuticals has an upper circuit limit of ₹862.05 and a lower circuit limit of ₹705.35. The total value traded stands at ₹25.74 CR, and the delivery percentage for the day is 55.84%.
The stock is currently traded with a market lot size of 1. Akums Drugs & Pharmaceuticals also offers a dividend yield of 0.38%.
Akums Drugs & Pharmaceuticals Share Price Chart
Akums Drugs & Pharmaceuticals Share Key Metrics
Volume
3.30 L
Market Cap
12334.97 CR
LTQ@LTP
1@783.70
ATP
778.82
Var Margin
17.29 %
Circuit Range
705.35-862.05
Delivery %
55.84 %
Value
25.74 CR
ASM/GSM
No
Market Lot
1
Akums Drugs & Pharmaceuticals Fundamentals
P/E Ratio
42.3
P/B Ratio
3.61
Div. Yield
0.38
Sector P/E
42.35
Sector P/B
3.6
Sec. Div. Yield
0.51
Akums Drugs & Pharmaceuticals Resistance and Support
Pivot 773.32
Resistance
First Resistance
782.74
Second Resistance
798.77
Third Resistance
808.19
Support
First Support
757.29
Second Support
747.87
Third Support
731.84
Akums Drugs & Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 18 2026 | 767.1 | 783.7 | 2.22% | 790 | 767.1 |
| Thu Sep 17 2026 | 768.09 | 766.7 | -0.69% | 789.34 | 763.9 |
| Wed Sep 16 2026 | 759.2 | 772 | 0.83% | 775 | 746.4 |
Akums Drugs & Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-08 | Quarterly Results |
| 2026-05-14 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-09 | Quarterly Results |
| 2024-08-24 | Quarterly Results |
Akums Drugs & Pharmaceuticals News
Akums Drugs and Pharmaceuticals Ltd - 544222 - ESG Rating
Akums Drugs & Pharma received an ESG rating of 65 for FY26 from NSE Sustainability Ratings & Analytics. The rating was voluntarily assigned based on publicly available data, not commissioned by the company.
Sep 03 2026 15:02:47
Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Akums Drugs & Pharma announced a scheduled group investor/analyst meet on September 2, 2026. The company will participate in the Ashwamedh – Elara India Dialogue 2026 at Hyatt, Santacruz East, Mumbai.
Aug 25 2026 16:51:23
Akums Drugs & Pharmaceuticals Management
| Name | Position |
|---|---|
| Sanjeev Jain | Managing Director |
| Sandeep Jain | Managing Director |
Akums Drugs & Pharmaceuticals Similar Stocks
Natco Pharma Ltd.
813.40
-4.85 (0.59%)
Marksans Pharma Ltd.
320.15
0.45 (0.14%)
CORONA Remedies Ltd.
2201.80
32.20 (1.48%)
Sudeep Pharma Ltd.
1155.00
49.60 (4.49%)
Alivus Life Sciences Ltd.
1430.80
43.00 (3.10%)
Metropolis Healthcare Ltd.
597.45
11.15 (1.90%)
Park Medi World Ltd.
282.05
4.15 (1.49%)
Sanofi Consumer Healthcare India Ltd.
4033.40
43.90 (1.10%)
Strides Pharma Science Ltd.
1219.80
19.60 (1.63%)
Blue Jet Healthcare Ltd.
575.25
7.05 (1.24%)
Akums Drugs & Pharmaceuticals FAQs
The Buying Price of Akums Drugs & Pharmaceuticals share is 783.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Akums Drugs & Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Akums Drugs & Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Akums Drugs & Pharmaceuticals shares is 42.3. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Akums Drugs & Pharmaceuticals shares is 3.61. Useful to assess the stock's value relative to its book value.
To assess Akums Drugs & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 42.35 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Akums Drugs & Pharmaceuticals is 12334.97 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Akums Drugs & Pharmaceuticals share price is 796.55 & 409.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Akums Drugs & Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in AKUMS
